A New Device Improves Signs and Symptoms of TMD
Background. Temporomandibular joint dysfunction (TMD) therapy remains an open challenge for modern dentistry. Herein, we propose a new neuromuscular lingual device able to reduce signs and symptoms of TMD in female patients with chronic orofacial pain. Methods. 50 females with myofascial TMD accordi...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2019-01-01
|
| Series: | Pain Research and Management |
| Online Access: | http://dx.doi.org/10.1155/2019/5646143 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832564177134157824 |
|---|---|
| author | Ruggero Cattaneo Davide Pietropaoli Barry C. Cooper Dino Capparè Eleonora Ortu Annalisa Monaco |
| author_facet | Ruggero Cattaneo Davide Pietropaoli Barry C. Cooper Dino Capparè Eleonora Ortu Annalisa Monaco |
| author_sort | Ruggero Cattaneo |
| collection | DOAJ |
| description | Background. Temporomandibular joint dysfunction (TMD) therapy remains an open challenge for modern dentistry. Herein, we propose a new neuromuscular lingual device able to reduce signs and symptoms of TMD in female patients with chronic orofacial pain. Methods. 50 females with myofascial TMD according to RDC/TMD were randomly assigned to study (n = 25) and control groups (n = 25). At T0, both groups received sEMG/KNG and pain evaluation by the VAS scale. The study group received the ELIBA device (lingual elevator by Balercia) constructed under ULF-TENS (ultra-low-frequency transcoutaneous electrical nervous stimulation). Subjects were instructed to use ELIBA at least for 16 h/day. After 6 months (T1), both groups underwent to sEMG/KNG and VAS revaluation. Results. T1 study group compared to controls showed a significant reduction in total (p<0.0001) and mean (p<0.0001) sEMG values, as well as a significant increase in both maximum vertical mouth opening (p=0.003) and maximum velocity in mouth opening (p=0.003) and closing (p<0.0001). Interestingly, a significant reduction in pain measured by VAS (p<0.0001) was reported. Conclusions. After 6 months, the ELIBA device is able to significantly reduce TMD-associated myogenous pain and to promote the enhancement of sEMG/KNG values. Practical Implications. ELIBA can be considered as a new device, potentially useful for head-neck pain relief in patients suffering from chronic TMD. In addition, its use promotes a muscles relaxation inducing freeway space increase. This characteristic makes it particularly useful for rehabilitation of patients with not enough space for construction of conventional orthotics or neuromuscular bites. |
| format | Article |
| id | doaj-art-22149c4979134f78a7dccfa557e10462 |
| institution | Kabale University |
| issn | 1203-6765 1918-1523 |
| language | English |
| publishDate | 2019-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Pain Research and Management |
| spelling | doaj-art-22149c4979134f78a7dccfa557e104622025-02-03T01:11:35ZengWileyPain Research and Management1203-67651918-15232019-01-01201910.1155/2019/56461435646143A New Device Improves Signs and Symptoms of TMDRuggero Cattaneo0Davide Pietropaoli1Barry C. Cooper2Dino Capparè3Eleonora Ortu4Annalisa Monaco5University of L’Aquila, Department of Life, Health and Environmental Sciences, San Salvatore Hospital, Building Delta 6–Unit of Dentistry, V.le San Salvatore, L’Aquila 67100, ItalyUniversity of L’Aquila, Department of Life, Health and Environmental Sciences, San Salvatore Hospital, Building Delta 6–Unit of Dentistry, V.le San Salvatore, L’Aquila 67100, ItalyDivision of Translational Oral Biology, School of Dental Medicine, State University of New York, Stony Brook, New York, NY 14214, USAPrivate Dental Technician, Dental Laboratory, Via Sallustio 4, 63074 San Benedetto Del Tronto (AP), ItalyUniversity of L’Aquila, Department of Life, Health and Environmental Sciences, San Salvatore Hospital, Building Delta 6–Unit of Dentistry, V.le San Salvatore, L’Aquila 67100, ItalyUniversity of L’Aquila, Department of Life, Health and Environmental Sciences, San Salvatore Hospital, Building Delta 6–Unit of Dentistry, V.le San Salvatore, L’Aquila 67100, ItalyBackground. Temporomandibular joint dysfunction (TMD) therapy remains an open challenge for modern dentistry. Herein, we propose a new neuromuscular lingual device able to reduce signs and symptoms of TMD in female patients with chronic orofacial pain. Methods. 50 females with myofascial TMD according to RDC/TMD were randomly assigned to study (n = 25) and control groups (n = 25). At T0, both groups received sEMG/KNG and pain evaluation by the VAS scale. The study group received the ELIBA device (lingual elevator by Balercia) constructed under ULF-TENS (ultra-low-frequency transcoutaneous electrical nervous stimulation). Subjects were instructed to use ELIBA at least for 16 h/day. After 6 months (T1), both groups underwent to sEMG/KNG and VAS revaluation. Results. T1 study group compared to controls showed a significant reduction in total (p<0.0001) and mean (p<0.0001) sEMG values, as well as a significant increase in both maximum vertical mouth opening (p=0.003) and maximum velocity in mouth opening (p=0.003) and closing (p<0.0001). Interestingly, a significant reduction in pain measured by VAS (p<0.0001) was reported. Conclusions. After 6 months, the ELIBA device is able to significantly reduce TMD-associated myogenous pain and to promote the enhancement of sEMG/KNG values. Practical Implications. ELIBA can be considered as a new device, potentially useful for head-neck pain relief in patients suffering from chronic TMD. In addition, its use promotes a muscles relaxation inducing freeway space increase. This characteristic makes it particularly useful for rehabilitation of patients with not enough space for construction of conventional orthotics or neuromuscular bites.http://dx.doi.org/10.1155/2019/5646143 |
| spellingShingle | Ruggero Cattaneo Davide Pietropaoli Barry C. Cooper Dino Capparè Eleonora Ortu Annalisa Monaco A New Device Improves Signs and Symptoms of TMD Pain Research and Management |
| title | A New Device Improves Signs and Symptoms of TMD |
| title_full | A New Device Improves Signs and Symptoms of TMD |
| title_fullStr | A New Device Improves Signs and Symptoms of TMD |
| title_full_unstemmed | A New Device Improves Signs and Symptoms of TMD |
| title_short | A New Device Improves Signs and Symptoms of TMD |
| title_sort | new device improves signs and symptoms of tmd |
| url | http://dx.doi.org/10.1155/2019/5646143 |
| work_keys_str_mv | AT ruggerocattaneo anewdeviceimprovessignsandsymptomsoftmd AT davidepietropaoli anewdeviceimprovessignsandsymptomsoftmd AT barryccooper anewdeviceimprovessignsandsymptomsoftmd AT dinocappare anewdeviceimprovessignsandsymptomsoftmd AT eleonoraortu anewdeviceimprovessignsandsymptomsoftmd AT annalisamonaco anewdeviceimprovessignsandsymptomsoftmd AT ruggerocattaneo newdeviceimprovessignsandsymptomsoftmd AT davidepietropaoli newdeviceimprovessignsandsymptomsoftmd AT barryccooper newdeviceimprovessignsandsymptomsoftmd AT dinocappare newdeviceimprovessignsandsymptomsoftmd AT eleonoraortu newdeviceimprovessignsandsymptomsoftmd AT annalisamonaco newdeviceimprovessignsandsymptomsoftmd |